Shigella is a contagious bacterial infection that spreads through contaminated food and water. Shigella test kits help doctors accurately diagnose patients showing symptoms of shigellosis such as bloody diarrhea, stomach cramps, and fever. The advantages of using shigella test kits include convenience, cost-effectiveness, and quick results. The global Shigella Test Kit Market is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The rising incidence of shigellosis across both developing and developed countries has accelerated the demand for shigella test kits over the past few years. According to the World Health Organization (WHO), shigellosis leads to approximately 200,000 deaths each year, majority being children under 5 years of age in developing countries. Early and accurate diagnosis plays a crucial role in controlling the spread of the disease. As a result, the adoption of commercially available shigella test kits is growing significantly among healthcare providers and laboratories for point-of-care diagnosis.
Segment Analysis
The global Shigella test kit market is dominated by the lateral flow assays segment. Lateral flow assays are the most commonly used and preferred test for initial screening of Shigella infections owing to rapid detection as well as ease of use. Results can be obtained within 30 minutes with lateral flow assays without any specialized equipment. The lateral flow assays segment accounted for over 50% of the global Shigella test kit market share in 2023.
Key Takeaways
The global Shigella test kit market is expected to witness high growth over the forecast period of 2023 to 2030. The market size is projected to reach US$ 106.4 Mn by 2024 growing at a CAGR of 5.9% through 2030.
North America is currently the dominant as well as the fastest growing regional market for Shigella test kits. High incidence of Shigella infections combined with strong healthcare infrastructure and widespread awareness about Shigella diagnostics are driving market growth in the region. The North America Shigella test kit market accounted for over 35% of the global market share in 2023.
Key players operating in the Shigella test kit market are Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc. These players are focusing on new product launches and geographic expansion to strengthen their market position.
No comments:
Post a Comment